Skip to main content
. 2020 Dec 18;14(1):100494. doi: 10.1016/j.waojou.2020.100494

Table 2.

Results for all scores

V1 mean score (95% CI) V3 mean score (95% CI) Difference V1 slope/min (95% CI) p Slope decrease between V1 and V3/min (95% CI) p V3 slope/min
TNSS 1.85 (1.66–2.04) 1.16 (1.01–1.36) - 36% 0.016 (0.012–0.020) <10−15 0.010 (0.015–0.0046) 0.0003 0.006
TESS 1.15 (0.96–1.34) 0.68 (0.56–0.79) - 41% 0.015 (0.012–0.019) <10−16 0.011 (0.015–0.006) <10−5 0.004
TBSS 0.71 (0.56–0.86) 0.36 (0.28–0.45) - 49% 0.0067 (0.0044–0.0091) <10−7 0.0065 (0.0098–0.0031) 0.0002 0.0002
TOSS 0.80 (0.68–0.93) 0.37 (0.30–0.44) - 54% 0.0083 (0.0064–0.010) <10−15 0.0064 (0.0091–0.0038) <10−5 0.0019
TSS 4.5 (3.9–5.1) 2.6 (2.3–2.9) - 43% 0.046 (0.037–0.055) <10−15 0.034 (0.047–0.021) <10−6 0.012

This table summarizes the results of the linear mixed effects model, analysing the symptom scores for their linear evolution over time. The mean scores (95% CI) during V1 and V3 and the percentage difference between baseline (V1) and final (V3) exposure are given. The slope per minute (95% CI) is given for V1 and the slope decrease between V1 and V3 per minute (95% CI) is shown including p-values as descriptive summary measures. V3 slope per minute is the difference between (V1 slope/min – slope decrease between V1 and V3/min)